Poop pills? fecal transplants show promise for gut infections
NCT ID NCT04090346
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested fecal microbiota transplant (FMT) in 24 adults with recurrent Clostridium difficile infection (C. diff) that didn't get better with standard antibiotics. FMT involves placing healthy donor stool into the patient's colon to restore good bacteria. The goal was to see if this treatment reduces the need for repeat transplants, surgery, or more antibiotics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIUM DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Mansfield Medical Center
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered yeast pill takes on superbug c. diff in first human trial
- New database aims to speed up FMT research for gut infections
- Should cancer patients get antibiotics for a dubious c. diff test? small trial seeks answers
- Poop pills? no, stool transplants aim to cure recurrent c. diff
- 4,000 patients join landmark poop transplant safety study
- Could a simple drink help clear confusion in hospitalized seniors?